NCT06334913Not yet recruiting
A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms
A Prospective Digital Monitoring Project Exploring Physical Activity, Patient Reported Outcome Measures and Disease Outcomes in Individuals With Myeloproliferative Neoplasms
Source: ClinicalTrials.gov · Last updated 28 Mar 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The investigators will assess the use of a smart phone app to monitor patient reported outcomes and record biometric data in patients with myeloproliferative neoplasms.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 13 Mar 2024
- Start date
- 1 Apr 2024
- Primary completion date
- 1 Apr 2029
- Lead sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Diseases
- Myeloproliferative neoplasms
- NCT number
- NCT06334913
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 1 Apr 2024 to the primary completion date, 1 Apr 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients with a known allergic reaction to any materials in the wearable device (substudy).
Other
- Patients who for any reason are not able to have a wearable (substudy). For example Withings ScanWatch should not be be used if the patient has an implantable electronic device such as a pacemaker or implantable cardioverter-defibrillator
Who the study is looking for
- Diagnosis of MPN.
- Resident in the UK
- Aged 18 years and over.
- Able to confidently converse in English language.
- Access to smartphone/ mobile phone.
- Capable of providing informed consent.
- Physically able to stand and ambulate independently (for substudy).
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.